A real-world pharmacovigilance study of cardiac adverse events induced by sugammadex in the FDA adverse event reporting system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A real-world pharmacovigilance study of cardiac adverse events induced by sugammadex in the FDA adverse event reporting system

Published:2024-08-29 Issue: Volume: Page:1-9
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Lin Xiao-Na¹,Zeng You-Jie²,Cao Si³,Jing Xi-Bo⁴

Affiliation:

1. Department of Cardiovascular Surgery, Shandong Second Provincial General Hospital, Jinan, China

2. Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China

3. Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-XIANGYA, Changsha, Hunan, China

4. Department of Structural Cardiology, Shandong Second Provincial General Hospital, Jinan, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2396645

Reference33 articles.

1. Guidelines on muscle relaxants and reversal in anaesthesia

2. Residual Neuromuscular Block

3. Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion

4. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function

5. Sugammadex: A Review of Neuromuscular Blockade Reversal

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP